Arranta Bio: Arranta Bio, MIT Partner to Develop Rapid Manufacturing of mRNA Therapeutics
Contract follows the largest award from FDA's Center for Biologics Evaluation and Research office to MIT.
Read full article »
Arranta Bio is a Massachusetts-based CDMO that provides services such as mRNA vaccine and microbiome LBP manufacturing for the pharmaceutical industry.
Read more